Skip to main content
JBIO logo

JBIO · Jade Biosciences, Inc. · Executive Compensation

Track JBIO — free
$15.31 +0.25 (+1.66%) At close · Nov 20
Market Cap
$1.06B
Shares
69.19M
Volume · Nov 20 1.02M Avg daily vol (3M) 911.9K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Tom Frohlich $9,799,759
Andrew King $4,541,804
Bradford Dahms $4,131,991
Timothy P. Noyes $1,814,483
Fiscal 2024
Executive Total
Timothy P. Noyes $3,391,536
Tom Frohlich $1,364,396
Andrew King $751,605
Fiscal 2021
Executive Total
Timothy P. Noyes $5,305,461
Benjamin T. Dake $2,878,821
George A. Eldridge $1,690,904
Hunter Gillies $1,632,478
Fiscal 2020
Executive Total
Benjamin T. Dake $502,119
Hunter Gillies $423,441

Executive changes

Person Change Filed
Mark Eisner, M.D., M.P.H. Appointed 2026-06-26
Andrew King Appointed 2026-04-22
Hetal Kocinsky, M.D. Resigned 2025-09-09
Bradford Dahms Appointed 2025-07-01
Eric Dobmeier Appointed 2025-05-01
Eric Dobmeier Appointed 2025-05-01
Erin Lavelle Appointed 2025-05-01
Lawrence Klein Appointed 2025-05-01
Tomas Kiselak Appointed 2025-05-01
Tom Frohlich Appointed 2025-05-01
Christopher Cain Appointed 2025-05-01
Eric Dobmeier Appointed 2025-05-01
Elizabeth Balta Appointed 2025-05-01
Hetal Kocinsky Appointed 2025-05-01
Jonathan Quick Appointed 2025-05-01
Andrew King Appointed 2025-05-01
George A. Eldridge Terminated 2025-05-01
Tom Frohlich Appointed 2025-05-01
Timothy P. Noyes Terminated 2025-05-01
Donald Santel
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Resigned 2025-05-01
Mark Iwicki Resigned 2025-05-01
Joshua Resnick
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Resigned 2025-05-01
David Grayzel
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Resigned 2025-05-01
Allison Dorval
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Resigned 2025-05-01
Habib Dable
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Resigned 2025-05-01

Leadership

Key facts CIK 1798749 CUSIP 008064206 13F (30d) 160 filings 151 filers Visit website Investor relations